Novavax Inc (NASDAQ:NVAX)

9.15
Delayed Data
As of Feb 27
 -0.16 / -1.72%
Today’s Change
3.34
Today|||52-Week Range
9.83
+54.30%
Year-to-Date
Frontrunning: February 27
Feb 27 / Investing Channel
 

Today’s Trading

Previous close9.31
Today’s open8.65
Day’s range8.51 - 9.25
Volume5,261,671
Average volume (3 months)5,027,776
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)-1.18%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...-0.21-1.37%
OPHTOphthotech Corp-1.06-1.94%
KITEKite Pharma Inc-2.05-3.04%
RLYPRelypsa Inc-0.17-0.44%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account